Funded by a $230,979 grant, an Ohio University study tests metformin to prevent Clostridioides difficile in heart patients.

The researchers conducted a double-blind, randomized, placebo-controlled trial involving 2,655 adults in 30 countries around the world. The study participants were suffering from primary or recurrent ...

After suffering repeated bouts of debilitating Clostridium difficile infections, many patients significantly change their behaviors, but some precautions may do little to prevent future infections, ...

University of Wisconsin–Madison–led researchers report lower yet statistically non-significant recurrence of Clostridioides difficile (C. diff) among adults given low-dose oral vancomycin during ...

"We found that fecal spores worked really well to protect people from a recurrence of C. diff," said McGill, who is also a professor of medicine. "But among the people who did recur, they had severe ...

— Greg Vigna, M.D., J.D. SANTA BARBARA, CA, UNITED STATES, August 3, 2023/EINPresswire.com/ -- “Prolonged IV antibiotics are necessary for the treatment of Grade ...

Clostridiumdifficile infection (also known as C. diff or CDI) is one of the most common hospital-acquired infections and is a frequent cause of death among hospitalized older adults. Keystone ...

FDA Approves Orphan Drug Fidaxomicin for Pediatric CDI The FDA has granted orphan drug designation for all formulations of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in ...